HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pavel S Dmitrenok Selected Research

Myelin Basic Protein

1/2021Multiple Sclerosis: Enzymatic Cross Site-Specific Hydrolysis of H1 Histone by IgGs against H1, H2A, H2B, H3, H4 Histones, and Myelin Basic Protein.
1/2013Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.
9/2012Multiple sites of the cleavage of 17- and 19-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.
4/2012Anti-integrase abzymes from the sera of HIV-infected patients specifically hydrolyze integrase but nonspecifically cleave short oligopeptides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pavel S Dmitrenok Research Topics

Disease

17Neoplasms (Cancer)
05/2022 - 04/2008
13Carcinoma (Carcinomatosis)
11/2019 - 04/2012
4Autoimmune Diseases (Autoimmune Disease)
06/2021 - 09/2015
4Multiple Sclerosis
01/2021 - 04/2012
3Leukemia
05/2022 - 06/2007
3Virus Diseases (Viral Diseases)
02/2022 - 01/2015
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2015 - 09/2012
2Neuroblastoma
11/2019 - 10/2017
2Colorectal Neoplasms (Colorectal Cancer)
03/2018 - 02/2017
1Neoplastic Cell Transformation
03/2022
1Breast Neoplasms (Breast Cancer)
06/2021
1Infections
11/2020
1Ascites
11/2019
1Adenocarcinoma
06/2019
1Acquired Immunodeficiency Syndrome (AIDS)
01/2018
1Immune System Diseases (Immune Disorders)
01/2018
1Schizophrenia (Dementia Praecox)
09/2015
1Acute-Phase Reaction
01/2015
1Bacterial Infections (Bacterial Infection)
01/2015
1Lymphoma (Lymphomas)
10/2014
1Melanoma (Melanoma, Malignant)
01/2012

Drug/Important Bio-Agent (IBA)

20GlycosidesIBA
05/2022 - 04/2008
8AntibodiesIBA
02/2022 - 09/2012
4Proteins (Proteins, Gene)FDA Link
02/2022 - 09/2012
4Immunoglobulin G (IgG)IBA
06/2021 - 04/2012
4Myelin Basic ProteinIBA
01/2021 - 04/2012
4AgarIBA
07/2012 - 06/2007
3TriterpenesIBA
03/2022 - 04/2008
3Deoxyribonucleases (DNase)FDA Link
06/2021 - 09/2015
3fucoidanIBA
03/2018 - 01/2012
3Sepharose (Agarose)IBA
01/2013 - 04/2012
2Epidermal Growth Factor (EGF)IBA
03/2022 - 06/2007
2Peptides (Polypeptides)IBA
02/2022 - 01/2015
2Histones (Histone)IBA
01/2021 - 01/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020 - 10/2017
2AutoantibodiesIBA
01/2018 - 09/2015
2AcidsIBA
10/2017 - 04/2008
2OligopeptidesIBA
01/2013 - 09/2012
2Peptide Hydrolases (Proteases)FDA Link
01/2013 - 09/2012
2cucumariosideIBA
09/2012 - 07/2012
1Sulfates (Sulfates, Inorganic)IBA
05/2022
1CarcinogensIBA
03/2022
1Hormones (Hormone)IBA
02/2022
1EnzymesIBA
02/2022
1Secretory Immunoglobulin A (SIgA)IBA
06/2021
1Poly UIBA
06/2021
1Peroxidase (Myeloperoxidase)IBA
06/2021
1echinochrome AIBA
11/2020
1Prostate-Specific Antigen (Semenogelase)IBA
08/2020
1psolusoside AIBA
06/2019
1NF-kappa B (NF-kB)IBA
12/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1Oxidopamine (6 Hydroxydopamine)IBA
10/2017
1ChromomycinsIBA
04/2017
1Cisplatin (Platino)FDA LinkGeneric
01/2016
1AutoantigensIBA
09/2015
1DNA (Deoxyribonucleic Acid)IBA
09/2015
1Biological ProductsIBA
10/2014
1Polysaccharides (Glycans)IBA
10/2014
12,5-dichloro-4-bromophenol (B 2)IBA
09/2014
1isorhizochalininIBA
12/2009
1shearinine EIBA
06/2007